Proceedings of the Epilepsy Foundation's 2017 Cannabinoids in Epilepsy Therapy Workshop

被引：0
作者：
Huizenga, Megan N. [1 ]
Fureman, Brandy E. [2 ]
Soltesz, Ivan [3 ]
Stella, Nephi [4 ,5 ]
机构：
[1] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC 20057 USA
[2] Epilepsy Fdn Amer, Res & New Therapies, Landover, MD USA
[3] Stanford Univ, Stanford Neurosci Inst, Dept Neurosurg, Stanford, CA 94305 USA
[4] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[5] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
来源：
EPILEPSY & BEHAVIOR | 2018年 / 85卷
关键词：
TREATMENT-RESISTANT EPILEPSY; REFRACTORY EPILEPSY; NEURAL CIRCUITS; DRAVET SYNDROME; CANNABIDIOL; SEIZURES; RECEPTORS; CB1; MODEL; PHARMACOLOGY;
D O I：
10.1016/j.yebeh.2018.05.016
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：237 / 242
页数：6
相关论文
共 53 条
  • [1] AMES FR, 1986, S AFR MED J, V69, P14
  • [2] β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling
    Anderson, Garret R.
    Aoto, Jason
    Tabuchi, Katsuhiko
    Foeldy, Csaba
    Covy, Jason
    Yee, Ada Xin
    Wu, Dick
    Lee, Sung-Jin
    Chen, Lu
    Malenka, Robert C.
    Suedhof, Thomas C.
    [J]. CELL, 2015, 162 (03) : 593 - 606
  • [3] Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy
    Barker-Haliski, Melissa L.
    Johnson, Kristina
    Billingsley, Peggy
    Huff, Jennifer
    Handy, Laura J.
    Khaleel, Rizvana
    Lu, Zhenmei
    Mau, Matthew J.
    Pruess, Timothy H.
    Rueda, Carlos
    Saunders, Gerald
    Underwood, Tristan K.
    Vanegas, Fabiola
    Smith, Misty D.
    West, Peter J.
    Wilcox, Karen S.
    [J]. NEUROCHEMICAL RESEARCH, 2017, 42 (07) : 1904 - 1918
  • [4] Correlated confocal and super-resolution imaging by VividSTORM
    Barna, Laszlo
    Dudok, Barna
    Miczan, Vivien
    Horvath, Andras
    Laszlo, Zsofia I.
    Katona, Istvan
    [J]. NATURE PROTOCOLS, 2016, 11 (01) : 163 - 183
  • [5] Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
    Barton, ME
    Klein, BD
    Wolf, HH
    White, HS
    [J]. EPILEPSY RESEARCH, 2001, 47 (03) : 217 - 227
  • [6] Molecular Targets of Cannabidiol in Neurological Disorders
    Bih, Clementino Ibeas
    Chen, Tong
    Nunn, Alistair V. W.
    Bazelot, Michael
    Dallas, Mark
    Whalley, Benjamin J.
    [J]. NEUROTHERAPEUTICS, 2015, 12 (04) : 699 - 730
  • [7] Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation
    Cabral, Guy A.
    Griffin-Thomas, LaToya
    [J]. EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
  • [8] CHRONIC ADMINISTRATION OF CANNABIDIOL TO HEALTHY-VOLUNTEERS AND EPILEPTIC PATIENTS
    CUNHA, JM
    CARLINI, EA
    PEREIRA, AE
    RAMOS, OL
    PIMENTEL, C
    GAGLIARDI, R
    SANVITO, WL
    LANDER, N
    MECHOULAM, R
    [J]. PHARMACOLOGY, 1980, 21 (03) : 175 - 185
  • [9] Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
    Devinsky, Orrin
    Cross, J. Helen
    Laux, Linda
    Marsh, Eric
    Miller, Ian
    Nabbout, Rima
    Scheffer, Ingrid E.
    Thiele, Elizabeth A.
    Wright, Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (21) : 2011 - 2020
  • [10] Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
    Devinsky, Orrin
    Marsh, Eric
    Friedman, Daniel
    Thiele, Elizabeth
    Laux, Linda
    Sullivan, Joseph
    Miller, Ian
    Flamini, Robert
    Wilfong, Angus
    Filloux, Francis
    Wong, Matthew
    Tilton, Nicole
    Bruno, Patricia
    Bluvstein, Judith
    Hedlund, Julie
    Kamens, Rebecca
    Maclean, Jane
    Nangia, Srishti
    Singhal, Nilika Shah
    Wilson, Carey A.
    Patel, Anup
    Cilio, Maria Roberta
    [J]. LANCET NEUROLOGY, 2016, 15 (03) : 270 - 278
123456